ArticleOncotarget2016

Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus.

Xiaochun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.